The aim of this study is to evaluate the inhibition of oxidative stress related enzymes of aqueous acetone extracts, as well as antibacterial activity from five Indigofera species well-known medicinal plant from Burkina. Also are investigated in this study the potential contribution of tannins and of flavonol in these activities Particularly, aqueous acetone extracts were investigated for their Lipoxygenase (LOX), Xanthine Oxidase (XO) and Acetylcholinesterase (AChE) inhibitions that are implied in inflammation, gout and Alzheimer's etiology diseases. Interestingly, I. macrocalyx which had the highest flavonol content (of all) showed more inhibition against LOX and XO (51.16 and 77.33% respectively). Our study showed a significant correlation between XO inhibition and total flavonol content (R 2 = 0.9052). AChE was low sensible to all extracts. In contrast, the extracts were rich in tannin compounds especially in I. tinctoria extract. And results of the in vitro antibacterial activities of these extracts against five bacteria showed that all bacteria were sensible to all extracts particularly S. typhimurium and B. cereus. Our results suggest that the five studied species prove to be good sources of inhibition of the three enzymes involved in oxidative stress and also to have some antibacterial properties. That is what probably explains their uses in folk medicine, singularly, in the treatment of gout, dysentery and anti-inflammatory diseases.
INTRODUCTION
Xanthine Oxidase (XO), Lipoxygenase (LOX) and Acetylcholinesterase (AChE) are enzymes involved in various oxidative stress diseases such as gout (Owen and Timothy, 1999 ) and Alzheimer's disease (Cole et al., 2005; Ferreira et al., 2006) and they are quiet implicated in several inflammatory processes (Wangensteen et al., 2006; Ziakas et al., 2006) .
Moreover, there is an increasing resistance of microorganisms against available antimicrobial agents and that is of major concern among scientists and clinicians worldwide. It is generally observed that pathogenic viruses, bacteria, fungi and protozoa are more and more difficult to treat with the existing drugs (Koomen et al., 2002) . In this current medical context, there is a constant need for new products to manage numerous infectious diseases such as tuberculoses, diarrhoeas, skin diseases, malaria as well as related oxidative stress diseases like gout, cancers, diabetes, arterioscleroses, rheumatisms, Alzheimer's and cardiovascular diseases (Halliwell and Guteride, 1990; Sweeney et al., 2001) .
The genus Indigofera comprises around 700 species distributed in tropical regions. In Burkina Faso, Nigeria and India, Indigofera colutea (Burm.) Murril. Indigofera macrocalyx Guild et Perr., Indigofera nigritana Hook f., Indigofera pulchra wild. and Indigofera tinctoria L. have intensive popular use in the treatment of various diseases as malaria, dysentery, constipation, stomach ache, fatigue, skin disease and wounds (Abubakar et al., 2007; Nacoulma, 1996; Perumal Samy et al., 1998) .
Their antimicrobial activity (Adamu et al., 2005; Dahot, 1999; Esimone et al., 1999; Leite et al., 2006; Maregesi et al., 2008; Thangadurai et al., 2002) , antioxidant activity (Bakasso et al., 2008; Gyamfi et al., 1999; Sreepriya et al., 2001) , antitumor activity (Han, 1994; Rajkapoor et al., 2004) and anti-inflammatory activity (Aziz-Ur-Rehman et al., 2005; Christina et al., 2003; Perumal Samy et al., 1998; Sharif et al., 2005) were also shown.
This study aims to evaluate the inhibition of oxidative stress related enzymes of aqueous acetone extracts from five Indigofera species and their antibacterial activity as well as the contribution of tannins and flavonol in these activities. 
MATERIALS AND METHODS

Chemical
Preparation of plant extracts:
For each plant, the freshly cut stems with leaves were dried at room temperature and ground to fine powder. Fifty gram of this powder was soaked in 500 mL of acetone: water (80:20 v/v) for 48 h under mechanical agitation (SM 25, Edmund BÜHLER, Germany, shaker), at room temperature. After filtration, acetone was removed under reduced pressure in a rotary evaporator (BÜCHI Rotavapor R-200, Switzerland) and the remaining aqueous solutions were lyophilised using a freeze drying system (Cryodos 50, TELSTAR, Spain).
Determination of total tannin and total flavonol contents: Tannins content was evaluated by the method of European Commission (2000). Briefly, distilled water (1 mL) was mixed with extract solution (0.2 mL; 10 mg/mL), ferric ammonium citrate (0.2 mL; 3.5 mg/mL in water) and ammonium hydroxide (0.2 mL; 0.8%). The mixture was incubated in darkness at room temperature for 15 min. A blank without extract was also prepared. The absorbance was measured at 525 nm against a standard curve of tannic acid. Tannin content was expressed as mg Tannic Acid Equivalent (TAE) /100 mg of extract.
Flavonol content was estimated as described by Almaraz-Abarca et al. (2004) . Aluminium trichloride (0.75 mL, 20% in ethanol) was mixed with the extract solution (0.75 mL, 1 mg/mL) and incubated for 10 min. Then the absorbance was read at 425 nm against a blank containing ethanol and the extract solution without aluminium chloride. Quercetin was used to produce the standard curve calibration and the results are expressed as mg Quercetin Equivalent (QE) /100 mg of extract.
Acetylcholinesterase (AChE) inhibition assay: AChE inhibiting activity was measured by the spectrophotometric method developed by Lopez et al. (2002) inspired from Ellman et al. (1961) method. Thanks to this method, the enzyme activity was determined by observing the increase of a yellow colour produced from thiocholine (resulting from acetylthiocholine hydrolysis by enzyme) when it reacts with DNTB (5, 5'-dithiobis-2-nitrobenzoic acid) ion. This can be detected at 405 nm (Rhee et al., 2001) . Ten percent methanol in buffer was used as negative control (enzyme activity without extract), Tris-HCl buffer 50 mM, pH 8, 0.1% BSA as enzyme blanck and Galanthamine as reference standard. The substrate ATCI (Acethylthiocholine Iodide) 15 mM was prepared in water and enzyme (0.22 U/mL) in Tris-HCl buffer 50 mM, pH 8, 0.1% BSA. Kinetic reaction was followed for 3 min. The percentage of enzyme inhibition (I %) of the enzymatic reaction was determined by the following equation:
where, E : The substrate hydrolysis kinetic by enzyme without test compound S : The substrate hydrolysis kinetic by enzyme with test compound
Lipoxygenase inhibition assay:
The inhibiting activity of Lipoxygenase was determined by the spectro photometric method described by Malterud and Rydland (2000) . The enzyme solution was obtained by preparing soybean LOX (EC 1.13.11.12) type I-B (200 U/mL) in borate buffer (167 U/mL for final concentration) with linoleic acid as substrate. Ten µL of linoleic acid, 30 µL of ethanol and 120 mL of borate buffer (pH 9.00) were mixed to obtain the test linoleic acid solution (134 µM for final concentration). Extracts (1 mg/mL) and reference (25 µg) were prepared initially in tween-20 and diluted in borate buffer (with 0.1% of final tween-20). After incubation of the mixture at 25°C for 3 mn, kinetic was read spectrophotometrically at 234 nm for 90s.
Xanthine oxidase inhibitory activity: The XO inhibitory activity was assayed on a CECIL spectrophotometer as described by Owen and Timothy (1999) with some modifications. The assay mixture consisted of 150 µL of phosphate buffer (0.066 M, pH 7.5), 50 µL of extract solution (1 mg/mL, in phosphate buffer), 50 µL of enzyme solution (0.28 U/mL). After pre-incubation at room temperature (25°C) for 3 min, the reaction was initiated by the addition of 250 µL of substrate solution (xanthine, 0.15 M in the same buffer). A blank without enzyme solution was also prepared. The reaction was monitored for 3 min at 295 nm and velocity (V 0 ) was recorded. Phosphate buffer was used as negative control (activity of the enzyme without extract solution). Allopurinol was used as positive control.
The percentage of XO inhibition was calculated as the following Eq. (1):
where, V 0 control : The activity of the enzyme in absence of the extract solution V 0 Sample : The activity of the enzyme in presence of the extract solution or allopurinol Antibacterial tests: The disc-diffusion assay was used to evaluate the antibacterial activity. Minimum Inhibitory Concentrations (MICs) of the extract were determined using the agar-well diffusion method. The MIC was taken as the lowest concentration of extract that caused a clear to semi-clear inhibition zone around the hole after 24 h incubation at 37°C (Cos et al., 2006; NCCLS, 2000) . One hundred µL of each concentration (150 mg/mL) was diluted in agar solution with decreasing concentrations from 75 to 0.58 mg/mL (first well to eighth). Then, 10 µL of a microbial suspension (10 5 colony forming units, CFU/mL), were added to each well. Plates were incubated at 37°C for 24 h. MIC was considered as the lowest concentration of the extract or positive control, showing no visible growth in the well.
Sterile Petri plates (d = 54 mm) were prepared by using sterile Müller-Hinton agar (Difco) for bacterial growth. Ten µL of the bacterial suspension was used to inoculate solidified MH agar. Then sterile filter paper discs (6 mm diameter) were applied on the solidified MH and 10 µL of plant extract was applied to sterile dics. Petri plates were incubated for 24 h at 37°C. The bacterial activity was evaluated by measuring the Diameter of Inhibition Zone (DIZ) formed around the disc. All tests were performed in triplicate. The five acetone aqueous extracts obtained were Dissolved in Dimethyl-Sulfoxide (DMSO) 10% to obtain 150 mg/mL as well as benzyl penicillin and ampicillin sodium used as control positive and DMSO 10% used as control negative. Each stock solution was sterilized by filtration through a 0.2 µm Millipore sterile filter.
Statistical analysis:
For statistical analysis, MS Excel software (CORREL Statistical function) was used to calculate quercetin and tannic acid equivalents, to determine inhibition percentage and to establish linear regression equations. One way ANOVA of JMP was used to determine the level of statistical significance respectively.
RESULTS AND DISCUSSION
In our previous investigation on five Indigofera species used in folk medicine in Burkina Faso, Polyphenols contents and antioxidant activities have been determined (Bakasso et al., 2008) .
The present study evaluates the biological activities of five Indigofera species related to their enzyme inhibition, their antimicrobial activities and their composition in tannins and flavonols.
Total tannin and total Flavonol contents in the aqueous acetone extracts of the five Indigofera species were estimated from calibration curves (Y = 0.0011x + 0.2236; R 2 = 0.9995 for total tannin and Y = 0.0353x + 0.0016, R 2 = 0.9988 for total flavonol) and the results are consigned in Table 1 . The highest total tannin content was recorded in I. tinctoria extract (26.63±0.12 mg TAE/100 mg) while the highest amount of flavonols was found in the extract of I. macrocalyx (2.93±0.07 mg QE/100 mg of dried extract). High levels of tannin were also found in I. nigritana and I. colutea. I. pulchra and I. colutea showed respectively the lowest flavonols content and tannin content. .85 Acetylcholinesterase (AchE), Lipoxygenase (LOX) and Xanthine Oxidase (XO) were performed at a final concentration of 100 µg/mL; Galanthamine Hbr (25 µg/mL), Quercetin (25 µg/mL) and Allopurinol (25 µg/mL) were used as standards; Tannin and flavonol are expressed respectively as mg of tannic acid equivalent (mg TAE/100 mg) and mg of quercetin equivalent (mg QE/100 mg) for 100 mg of dried extract; Data are expressed as mean values±standard deviation (n = 3); Values within each column with different superscript letters ( a, b, c ) are significantly different (p<0.05) as determined using ANOVA The qualitative and quantitative composition in these phytochemical compounds can partially justify some of the medicinal uses of Indigofera species in Burkina Faso particularly to cure inflammation, skin diseases and gout.
Enzyme inhibition percentages ----------------------------------------------------------------------------------
The inhibitory activity of AChE by the five Indigofera species was presented in Table 1 . At a final concentration of 100 µg/mL, highest inhibition was found in I. nigritana extract (36.06±3.67%) and I. colutea extract (32.24±2.10%). The lowest percent data was found in I. pulchra and I. tinctoria extracts. These results showed that I. colutea and I. nigritana which have the highest phenolic content (Bakasso et al., 2008) were found to possess the high inhibition of AChE. A low correlation was found between AChE inhibition and total flavonol or total tannin content ( Fig. 1 and 2 ). Those correlations suggested that tannin and flavonol have a little contribution in AChE inhibition. However, the inhibition might come from the presence of phenolic acids, flavonoids and other antioxidant compounds. These results are in agreement with our previous investigation where we showed that I. colutea and I. nigritana had high antioxidant activity (Bakasso et al., 2008) ; consequently, antioxidant compounds might be implicated in AChE inhibition (Ferreira et al., 2006) . Recent studies bound Alzheimer's disease to an inflammatory process induced by reactive oxygenated substances (Cole et al., 2005) . The oxidative stress intervenes, for a share, in the physiopathology of the neuronal degeneration. AChE enzyme is considered to be related to the mechanism of memory dysfunction as Alzheimer's Disease (AD). Our extracts, particularly I. colutea and I. nigritana extracts which have the best inhibition of AChE could thus be sources of drugs to manage Alzheimer's disease; they could also have some insecticide properties since this enzyme also intervenes in insect resistance. Galanthamine was used as standard AChE inhibitor and showed at 25 µg/mL inhibition amount 52.85%. Lipoxygenase (LOX) is an enzyme involve in various oxidative stress disorders such as inflammation, arthritis, cancer and autoimmune diseases (Cole et al., 2005) .
The anti-inflammatory activity of the five extracts of Indigofera was evaluated by measuring the inhibition of LOX using linoleic acid as substrate. The results were reported in Table 1 . All of the five extracts showed inhibition percentage above 39% at 100 µg/mL. The highest inhibition was found in I. colutea (56.61±2.83%) and I. macrocalyx (51.18±9.53%) extracts. No significant differences between I. nigritana, I. pulchra and I. tinctoria inhibitions on LOX. The standard quercetin showed 52.55% inhibition at 25 µg/mL. It should be noted that the significant activity I. colutea was showing may be due to the presence of gallic acid identified in the extract of this plant (Bakasso et al., 2008) and recognized as made up of anti-inflammatory compounds. These results can justify the use of I. colutea to relieve stomachs ache (Perumal Samy et al., 1998) . Other Indigofera species were previously showed to exhibit good inhibition activity against LOX (Aziz-Ur- Rehman et al., 2005; Sadik et al., 2003; Sharif et al., 2005) .
Xanthine Oxidase (XO) activity is implicated in the etiology of gout, an inflammatory disorder characterized by the deposit of uric acid on the articulations. The production of uric acid can be blocked by inhibiting this enzyme and consequently cure the problems of gout (Chiang et al., 1994) . XO inhibitors are known to be therapeutically useful for the treatment of gout, hepatitis and brain tumor (Filha et al., 2006; Song et al., 2003) . For that, the five Indigofera aqueous acetone extracts were tested against XO. The results are presented in Table 1 . Among the five plant extracts, four gave a data percentage of the XO inhibition superior to 33% at 100 µg/mL (final concentration). I. macrocalyx with 77.33±7.57% gave the best inhibition followed by I. tinctoria (42.42±1.05%). The lowest inhibition activity was found in I. colutea extract (15.19±5.25%). The best inhibition obtained with I. macrocalyx extract can be explained by its high flavonol content. Investigation on the XO inhibition showed that the flavonoids and, in particular, the flavonol plays a significant role in the inhibition of this enzyme (Nagao et al., 1999; Raj Narayana et al., 2001) .
Previous studies showed I. macrocalyx methanol extract XO inhibitory activity (Bangou et al., 2011) This last assertion is strongly supported by the positive correlation obtained between flavonol content and XO (R 2 = 0.9052) (Fig. 1) . The inhibiting compounds of XO have biological potentials in the treatment of gout or other diseases induced by XO activity (Kong et al., 2000; Sweeney et al., 2001) . It is recognized that the inhibitors of XO are used in the treatment of hepatitis and tumours of the brain. Allopurinol used as a positive control exhibited an inhibition percentage of 91.25% on XO at 25 µg/mL. The antibacterial activity of the five Indigofera species was evaluated on five bacterial strains. The results of diameter of inhibition zone are reported in Table 2 .
These results indicated that Ampicillin and Penicillin, two broad spectrum antibiotics, exerted strong inhibitions against four of the five tested strains (diameter >53 mm). But Bacillus cereus showed resistance to the two antibiotics while it displayed susceptibility of all the extracts; that could be explained by the development of enzymes such as β-lactamase by these bacteria, being able to neutralize the effect of those antibiotics.
All of the extracts express activity against the tested strains but E. coli was the most resistant. I. colutea, I. macrocalyx and I. tinctoria are more active than the other extracts on bacterial strains. The best diameters are obtained by I. colutea extract on S. typhimurium (16±1) and on P. mirabilis (15.67±1.15 mm). Maregesi et al. (2008) found that the extracts of I. colutea strongly inhibited the growth of B. cereus and S. aureus stains. Adamu et al. (2005) found that I. pulchra exhibited activity against S. aureus and P. mirabilis. Other investigations showed that some Indigofera species are active against S. aureus, E. coli, S. typhimurium (Esimone et al., 1999; Leite et al., 2006) . In our previous investigation, I. colutea showed the best phenolic compounds content among the other Indigofera species (Bakasso et al., 2008) . Polyphenols compounds such as phenolic acid, tannin and flavonoid are important antibacterial compounds and constitute a factor of toxicity for the micro-organisms (Scalbert, 1991) . In this study, the antibacterial activity of the five Indigofera species can be explained by the significant correlations obtained between flavonol content and inhibition zones against E. coli (R 2 = 0.6669) (Fig. 3) . Those results also showed that in general Grampositive bacteria are more sensitive than Gram-negative ones. Gram-negative bacteria possess an outer membrane and cell wall in comparison with the Grampositive bacteria that could explain the weak sensibility of Gram-negative bacteria contrary to the Grampositive which have not outer membrane and cell wall structure (Shan et al., 2007) . Indeed, the mechanism of phenolic toxicity against bacteria could be through the inhibition of the hydrolytic enzymes, however, with other interactions to set of the bacterial adhesion, proteins of transport of the cell outer membrane and the non specific interaction with the carbohydrates. Phenolic compounds can also be the cause of the deprivation of iron or the hydrogen bonds of the bacterial enzymes (Scalbert, 1991) . The MIC of the different extract is consigned in Table 3 . A very low MIC corresponds to a very strong antibacterial activity. These concentrations are between 9.37 and 37.5 mg/mL. I. colutea, I. macrocalyx and I. tinctoria showed the same activity against the various bacteria strains.
The antibacterial activity highlighted would confirm the therapeutic use of certain Indigofera sp., in folk medicine against skin disease and other bacterial infections (Adamou et al., 2005; Nacoulma, 1996) .
CONCLUSION
This investigation showed that Indigofera species, used in folk medicine in Burkina Faso, are active on all stocks bacterial tested. In addition the enzymatic activities showed that LOX and XO are more inhibited than AChE. Moreover, I. macrocalyx the richest extract in flavonol, was found to possess the strongest activity against XO. According, the plants used in this study represent a good source for XO and LOX inhibitors and also for antibacterial compounds. These results give, once again, further support to the therapeutically uses of these Indigofera species.
Future studies aim to isolate and identify these active constituents that exhibit significant XO and LOX inhibitory activity through bioassay-guided.
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